Solid-IO

Solid-IO is revolutionizing cancer care by eliminating guesswork and enhancing accessibility to immunotherapy drugs with a scalable and fast solution. Through the miniaturization of a patient’s tumor and immune cells in distinctive organ-on-a-chip assays, Solid-IO recreates an individual’s specific antitumor immunity. This empowers oncologists to make informed decisions when choosing personalized treatments for their patients.